Peripheral Immune Cell Profiles as Predictive Biomarkers of Immune Checkpoint Inhibitor Efficacy in Elderly Patients With Advanced Non‐Small Cell Lung Cancer
Peripheral cytotoxic T cell subsets may serve as promising biomarkers for predicting the efficacy of ICIs in elderly NSCLC patients. Dynamic monitoring of immune cell profiles could further enhance prognostic accuracy.
Authors
- S. H. Wang
- Yilin Pang (ORCID: https://orcid.org/0000-0003-4920-2423)
- Quan Zhang (ORCID: https://orcid.org/0000-0002-9039-4140)
- Xi Li (ORCID: https://orcid.org/0000-0003-2799-0502)
- Yilin Wang (ORCID: https://orcid.org/0000-0002-8261-7439)
- Jialin Lv
- Ying Hu
Institutions
- Beijing Chest Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/1759-7714.70202
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00